Kinaxis Inc. (KXS.TO) – What Are Researchers Thinking About This Stock?

Shares of Kinaxis Inc. (TSE:KXS – Get Free Report) have been given an average recommendation of “Buy” by the eight analysts that are presently covering the company, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued a report on the stock in the last year is C$210.56.

KXS has been the topic of a number of analyst reports. Stifel Nicolaus increased their price target on Kinaxis from C$200.00 to C$225.00 and gave the company a “buy” rating in a research note on Thursday, October 29th. RBC Dominion Securities set a C$210.00 price objective on Kinaxis and gave the stock an “outperform” rating in a research note on Friday, October 23rd. Royal Bank Of Canada set a C$210.00 price objective on Kinaxis and gave the stock an “outperform” rating in a research note on Wednesday, August 26th. BMO Capital Markets upped their price objective on Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Finally, National Bank Financial increased their target price on Kinaxis from C$210.00 to C$245.00 and gave the company an “outperform” rating in a research note on Monday, November 9th.

Read Our Latest Stock Analysis on KXS

Insider Activity

In related news, insider David Peter Kelly sold 1,603 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of C$177.68, for a total value of C$284,821.04. Following the sale, the insider directly owned 358 shares of the company’s stock, valued at approximately C$63,609.44. The trade was a 81.74% decrease in their position. Also, insider James Alexander Hollingworth sold 2,150 shares of the company’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of C$178.94, for a total value of C$384,721.00. Following the transaction, the insider directly owned 4,772 shares of the company’s stock, valued at C$853,901.68. This represents a 31.06% decrease in their ownership of the stock. In the last quarter, insiders sold 13,076 shares of company stock valued at $2,335,260. Company insiders own 1.20% of the company’s stock.

Kinaxis Price Performance

Kinaxis stock traded up C$1.10 on Friday, reaching C$229.24. The company’s stock had a trading volume of 197,561 shares, compared to its average volume of 129,074. The business’s fifty day moving average price is C$187.40 and its 200 day moving average price is C$158.41. The company has a debt-to-equity ratio of 11.18, a quick ratio of 2.29 and a current ratio of 1.81. The company has a market cap of C$6.21 billion, a price-to-earnings ratio of 71.64, a PEG ratio of 3.60 and a beta of 0.43. Kinaxis has a twelve month low of C$117.22 and a twelve month high of C$231.91.

Kinaxis (TSE:KXS – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported C$1.72 earnings per share for the quarter. The business had revenue of C$228.16 million during the quarter. Kinaxis had a net margin of 14.33% and a return on equity of 22.26%. Equities analysts expect that Kinaxis will post 4.25 earnings per share for the current fiscal year.

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Further Reading

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.